High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial-Reference-Cited by-同舟云学术

High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial

Published:2022-05 Issue:5 Volume:23 Page:671-681
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Zapatero Almudena,Guerrero Araceli,Maldonado Xavier,Álvarez Ana,San-Segundo Carmen González,Rodríguez María Ángeles Cabeza,Solé Josep María,Olivé Agustí Pedro,Casas Francesc,Boladeras Ana,de Vidales Carmen Martín,de la Torre María Luisa Vázquez,Vara Susana,Sanz Juan Luis,Calvo Felipe A

Publisher

Elsevier BV

Subject

Oncology

Reference25 articles.

1. Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610;Roach;J Clin Oncol,2008

2. External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study;Bolla;Lancet Oncol,2010

3. Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer;Horwitz;J Clin Oncol,2008

4. Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial;D'Amico;JAMA,2008

5. Duration of androgen deprivation in locally advanced prostate cancer: long-term update of NRG Oncology RTOG 9202;Lawton;Int J Radiat Oncol Biol Phys,2017

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Androgen Deprivation Therapy (ADT) integration in prostate cancer: Insights for Stereotactic Body Radiotherapy (SBRT) and brachytherapy modalities;Clinical and Translational Radiation Oncology;2024-03

2. Can Extreme Dose Escalation With External Beam Radiation Therapy and Low-Dose-Rate Brachytherapy Boost Obviate the Need for Long-Term Androgen Deprivation Therapy in Patients With High-Risk Localized Prostate Cancer?;International Journal of Radiation Oncology*Biology*Physics;2024-02

3. Trimodality Therapy With Iodine-125 Brachytherapy, External Beam Radiation Therapy, and Short- or Long-Term Androgen Deprivation Therapy for High-Risk Localized Prostate Cancer: Results of a Multicenter, Randomized Phase 3 Trial (TRIP/TRIGU0907);International Journal of Radiation Oncology*Biology*Physics;2024-02

4. Review of Current Treatment Intensification Strategies for Prostate Cancer Patients;Cancers;2023-11-28

5. Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancer;World Journal of Urology;2023-11-15